SignalFire has invested in Solace Health, a healthcare advocacy company valued at over $1 billion, to capitalize on its innovative full-stack platform and strategic positioning in the evolving U.S. healthcare landscape following the introduction of reimbursable patient navigation services.

Information on the target

Solace Health is a pioneering healthcare advocacy company dedicated to bridging the gaps in the U.S. healthcare system. Founded by Jeremy Gurewitz, Solace was inspired by personal experiences with the complexities of healthcare navigation, particularly during critical moments of patient care. The company pairs patients with dedicated healthcare advocates, including nurses and social workers, who assist in coordinating care, managing logistics, and ensuring that patients receive the support they need during vulnerable times. With a recent valuation exceeding $1 billion following a $130 million Series C funding round, Solace is poised to redefine healthcare advocacy as an essential component of care delivery.

Industry overview in the target’s specific country

The U.S. healthcare industry is characterized by significant spending, yet it remains fraught with challenges that hinder patient access and care coordination. Despite trillions of dollars invested annually, nearly 40% of patients delay or avoid necessary care due to confusion, cost, and systemic friction. This fragmentation leads to missed diagnoses, preventable hospitalizations, and increased caregiver burnout, resulting in billions of dollars in unnecessary costs. The need for effective solutions to navigate this complex landscape has never been more pressing.

In recent years, there has been a growing recognition of the importance of patient advocacy as a means to improve healthcare outcomes. The introduction of reimbursement codes for Community Health Integration (CHI) and Principal Illness Navigation (PIN) by CMS in 2024 marks a significant s